Sanofi has announced an increase in net income from continuing operations for the fourth quarter (Q4) of 2024, reaching €880m ...

The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various ...

The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...

Daiichi Sankyo has announced that Hiroyuki Okuzawa will succeed Sunao Manabe as chief executive officer from 1 April 2025.

AI could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to ...

The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.

During a Senate HELP Committee hearing, RFK Jr. stated that President Trump is dedicated to bringing drug manufacturing "back ...

Takeda has announced the appointment of Julie Kim as the successor to Christophe Weber, effective from June 2026.

The pathway allows medicine developers to work with the regulators, the NHS and health technology assessment bodies.

Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for ...

Acellera and Psivant have announced a strategic research partnership aimed at developing computational drug discovery ...

Prioritising US health, Trump has already frozen the supply of HIV and malaria medication aid to endemic countries.